Pharma stocks probably less risky: Prateek Agarwal

Prateek Agarwal, Head Equities, Bharti AXA Invest Manager, in a chat with ET Now on pharma stocks.

What would you do with select pharma stocks essentially be stock specific but would you look at midcap pharma at all because after we have talked about how an Aurobindo or Strides have made a huge move.

Since then they have been stagnating at those levels and some of the other ones as well aside of may be an Orchid which has made a move they have not really made a move of sorts would you look at that side of the market now?

I would think so these are businesses which are growing at similar to or higher than FMCG kind of growth rates and lot of the midcap companies actually have business models which are like FMCG in terms of promotion of a brand.

Pharmaceuticals are probably less risky and to our mind better place than some of the other areas in the market at this point in time.